Telmisartan/hydrochlorothiazide
| Combination of | |
|---|---|
| Telmisartan | Angiotensin II receptor antagonist |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| MedlinePlus | a611031 |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| (verify) | |
Telmisartan/hydrochlorothiazide (INNs, trade names MicardisPlus or Micardis HCT) is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide,[1][2] the most common diuretic to be combined with other blood pressure lowering substances.
References
- ^ Drugs.com: Micardis HCT
- ^ "Hypertension". Boehringer Ingelheim GmbH. Retrieved 6 March 2015.
{{cite web}}: Cite has empty unknown parameter:|1=(help)
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |